

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adhesion of symbiont to host cell (GO:0044650) | 3.94981627 |
| 2 | virion attachment to host cell (GO:0019062) | 3.94981627 |
| 3 | adhesion of symbiont to host (GO:0044406) | 3.34682685 |
| 4 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.32439027 |
| 5 | behavioral response to nicotine (GO:0035095) | 2.82614708 |
| 6 | regulation of autophagic vacuole assembly (GO:2000785) | 2.69825681 |
| 7 | tooth mineralization (GO:0034505) | 2.69449200 |
| 8 | cellular response to ATP (GO:0071318) | 2.67713737 |
| 9 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62781242 |
| 10 | mannose metabolic process (GO:0006013) | 2.57283167 |
| 11 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.54936736 |
| 12 | response to acidic pH (GO:0010447) | 2.49414102 |
| 13 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.47362515 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.46365095 |
| 15 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.45893754 |
| 16 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.44247338 |
| 17 | cellular response to pH (GO:0071467) | 2.43653814 |
| 18 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.40179091 |
| 19 | regulation of vacuole organization (GO:0044088) | 2.38566020 |
| 20 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.37890201 |
| 21 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.32767788 |
| 22 | axoneme assembly (GO:0035082) | 2.24466074 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.23637140 |
| 24 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.22585861 |
| 25 | urinary tract smooth muscle contraction (GO:0014848) | 2.21584288 |
| 26 | alanine transport (GO:0032328) | 2.21095792 |
| 27 | epithelial cilium movement (GO:0003351) | 2.20237134 |
| 28 | opioid receptor signaling pathway (GO:0038003) | 2.18317149 |
| 29 | motile cilium assembly (GO:0044458) | 2.17365589 |
| 30 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.17167356 |
| 31 | negative regulation of amino acid transport (GO:0051956) | 2.16048861 |
| 32 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.14882674 |
| 33 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.14362813 |
| 34 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.13984962 |
| 35 | glycerophospholipid catabolic process (GO:0046475) | 2.12255136 |
| 36 | positive regulation of T cell apoptotic process (GO:0070234) | 2.11724255 |
| 37 | cell-cell junction maintenance (GO:0045217) | 2.10798891 |
| 38 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.09894377 |
| 39 | lytic vacuole organization (GO:0080171) | 2.09776768 |
| 40 | lysosome organization (GO:0007040) | 2.09776768 |
| 41 | potassium ion export (GO:0071435) | 2.09192853 |
| 42 | amine catabolic process (GO:0009310) | 2.06306761 |
| 43 | cellular biogenic amine catabolic process (GO:0042402) | 2.06306761 |
| 44 | negative regulation of mast cell activation (GO:0033004) | 2.05150800 |
| 45 | positive regulation of fatty acid oxidation (GO:0046321) | 2.05025295 |
| 46 | response to pH (GO:0009268) | 2.04530755 |
| 47 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.03427752 |
| 48 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.01976203 |
| 49 | axonemal dynein complex assembly (GO:0070286) | 2.01614514 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 2.01157083 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 2.01157083 |
| 52 | tryptophan catabolic process (GO:0006569) | 2.01157083 |
| 53 | membrane repolarization during action potential (GO:0086011) | 2.00858984 |
| 54 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.00602006 |
| 55 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.99819810 |
| 56 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 1.99560068 |
| 57 | response to dietary excess (GO:0002021) | 1.99222204 |
| 58 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.98785761 |
| 59 | positive regulation of protein dephosphorylation (GO:0035307) | 1.96533652 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 1.94198943 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 1.93567852 |
| 62 | regulation of sequestering of triglyceride (GO:0010889) | 1.93375849 |
| 63 | negative regulation of interleukin-1 production (GO:0032692) | 1.91826037 |
| 64 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 1.91605727 |
| 65 | phagosome maturation (GO:0090382) | 1.91152574 |
| 66 | synaptic vesicle exocytosis (GO:0016079) | 1.90961185 |
| 67 | type B pancreatic cell proliferation (GO:0044342) | 1.89957023 |
| 68 | synaptic vesicle maturation (GO:0016188) | 1.88307647 |
| 69 | serotonin metabolic process (GO:0042428) | 1.87554186 |
| 70 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.87540987 |
| 71 | positive regulation of histone deacetylation (GO:0031065) | 1.86432505 |
| 72 | arginine catabolic process (GO:0006527) | 1.86225481 |
| 73 | positive regulation of protein kinase C signaling (GO:0090037) | 1.85904863 |
| 74 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 1.85825225 |
| 75 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 1.85158689 |
| 76 | kynurenine metabolic process (GO:0070189) | 1.84269136 |
| 77 | positive regulation of action potential (GO:0045760) | 1.83798669 |
| 78 | phenol-containing compound catabolic process (GO:0019336) | 1.83021019 |
| 79 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.82942789 |
| 80 | hydrogen peroxide biosynthetic process (GO:0050665) | 1.80963205 |
| 81 | cellular response to zinc ion (GO:0071294) | 1.80900608 |
| 82 | glutamate secretion (GO:0014047) | 1.80744486 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 1.79871902 |
| 84 | protein heterotrimerization (GO:0070208) | 1.79016577 |
| 85 | regulation of triglyceride metabolic process (GO:0090207) | 1.78248449 |
| 86 | positive regulation of defense response to virus by host (GO:0002230) | 1.77722779 |
| 87 | primary amino compound metabolic process (GO:1901160) | 1.77591761 |
| 88 | cilium movement (GO:0003341) | 1.77466320 |
| 89 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.76261833 |
| 90 | cellular response to nutrient (GO:0031670) | 1.76027868 |
| 91 | adaptation of signaling pathway (GO:0023058) | 1.75856252 |
| 92 | positive regulation of heat generation (GO:0031652) | 1.75150449 |
| 93 | regulation of sensory perception (GO:0051931) | 1.75133931 |
| 94 | regulation of sensory perception of pain (GO:0051930) | 1.75133931 |
| 95 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 1.75085273 |
| 96 | regulation of chemokine biosynthetic process (GO:0045073) | 1.74954575 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 1.73594770 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.73594770 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.73594770 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 1.73594770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.86953496 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.42098627 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.29630564 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11679724 |
| 5 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.08551270 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93334712 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91376945 |
| 8 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90943629 |
| 9 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87131582 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86580256 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85482571 |
| 12 | P68_20966046_ChIP-Seq_HELA_Human | 1.80313563 |
| 13 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79868572 |
| 14 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.77825665 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.70982366 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.69237966 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68540891 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63140647 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62317410 |
| 20 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.61837738 |
| 21 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56549214 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56100241 |
| 23 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56072965 |
| 24 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54173364 |
| 25 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.53932839 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52479677 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52006146 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51699593 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51646848 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51054815 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50065216 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47612174 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46872818 |
| 34 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.46859074 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44867804 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44649929 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44448560 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43871825 |
| 39 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.42460258 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42332514 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42332514 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41455084 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41374957 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41236735 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40624507 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39488971 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39392066 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.37402927 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36820703 |
| 50 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.36033183 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35905630 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34031368 |
| 53 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.32926187 |
| 54 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31831138 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31202198 |
| 56 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.30993158 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.29339917 |
| 58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28189813 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.28108749 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.27017878 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.26244137 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.25977320 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25816558 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25493915 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25478112 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23493248 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22889087 |
| 68 | ERA_21632823_ChIP-Seq_H3396_Human | 1.22555938 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21435047 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17688917 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16868685 |
| 72 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15817430 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15369646 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14697727 |
| 75 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.13660366 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12814212 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10038730 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09850712 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09227195 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08261693 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08112164 |
| 82 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.07747700 |
| 83 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06290216 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04827400 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04599904 |
| 86 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04202166 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03026246 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02654528 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02435418 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 1.00529525 |
| 91 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97622702 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97476479 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96497412 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95773741 |
| 95 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.95555540 |
| 96 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.95226296 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94507917 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92078590 |
| 99 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90876246 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.89694762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 2.54468124 |
| 2 | MP0003879_abnormal_hair_cell | 2.30141639 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.27782009 |
| 4 | MP0001968_abnormal_touch/_nociception | 2.09924482 |
| 5 | MP0001501_abnormal_sleep_pattern | 1.89325432 |
| 6 | MP0002733_abnormal_thermal_nociception | 1.89265157 |
| 7 | MP0001970_abnormal_pain_threshold | 1.87528006 |
| 8 | MP0004130_abnormal_muscle_cell | 1.84903427 |
| 9 | MP0004510_myositis | 1.82414990 |
| 10 | MP0009745_abnormal_behavioral_response | 1.65820320 |
| 11 | MP0003172_abnormal_lysosome_physiology | 1.65713169 |
| 12 | MP0002653_abnormal_ependyma_morphology | 1.64155791 |
| 13 | MP0002876_abnormal_thyroid_physiology | 1.63895720 |
| 14 | MP0002064_seizures | 1.60602755 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 1.59956458 |
| 16 | MP0001542_abnormal_bone_strength | 1.58864402 |
| 17 | MP0001905_abnormal_dopamine_level | 1.57567974 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 1.56263026 |
| 19 | MP0001986_abnormal_taste_sensitivity | 1.53184398 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52873609 |
| 21 | MP0003436_decreased_susceptibility_to | 1.51968205 |
| 22 | MP0002736_abnormal_nociception_after | 1.49272207 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 1.48478348 |
| 24 | MP0003724_increased_susceptibility_to | 1.47364267 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.47241493 |
| 26 | MP0003279_aneurysm | 1.45660793 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.40464393 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.40321867 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.38642410 |
| 30 | MP0003303_peritoneal_inflammation | 1.36430390 |
| 31 | MP0003075_altered_response_to | 1.35154642 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.33008618 |
| 33 | MP0002272_abnormal_nervous_system | 1.32400590 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.32141966 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.31688497 |
| 36 | MP0009764_decreased_sensitivity_to | 1.31632001 |
| 37 | MP0003329_amyloid_beta_deposits | 1.31599304 |
| 38 | MP0000343_altered_response_to | 1.29663252 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.29166633 |
| 40 | MP0006082_CNS_inflammation | 1.27867448 |
| 41 | MP0004043_abnormal_pH_regulation | 1.27833215 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.25779170 |
| 43 | MP0005595_abnormal_vascular_smooth | 1.25304047 |
| 44 | MP0004885_abnormal_endolymph | 1.24392546 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.22083800 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.21248192 |
| 47 | MP0003878_abnormal_ear_physiology | 1.21248192 |
| 48 | MP0004858_abnormal_nervous_system | 1.17384000 |
| 49 | MP0001663_abnormal_digestive_system | 1.17260581 |
| 50 | MP0009046_muscle_twitch | 1.15613967 |
| 51 | MP0002734_abnormal_mechanical_nocicepti | 1.13646983 |
| 52 | MP0005535_abnormal_body_temperature | 1.13073712 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.10303233 |
| 54 | MP0000230_abnormal_systemic_arterial | 1.08691467 |
| 55 | MP0009785_altered_susceptibility_to | 1.06686233 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.06072193 |
| 57 | MP0003011_delayed_dark_adaptation | 1.04103136 |
| 58 | MP0001765_abnormal_ion_homeostasis | 1.02736981 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.01719009 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.00836394 |
| 61 | MP0003787_abnormal_imprinting | 1.00321485 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.00016297 |
| 63 | MP0005670_abnormal_white_adipose | 0.99852791 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 0.99389407 |
| 65 | MP0001958_emphysema | 0.99079611 |
| 66 | MP0000604_amyloidosis | 0.98708919 |
| 67 | MP0002295_abnormal_pulmonary_circulatio | 0.97546587 |
| 68 | MP0002557_abnormal_social/conspecific_i | 0.96856080 |
| 69 | MP0005390_skeleton_phenotype | 0.96000216 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.93985098 |
| 71 | MP0001756_abnormal_urination | 0.92628169 |
| 72 | MP0000681_abnormal_thyroid_gland | 0.90646068 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 0.90198659 |
| 74 | MP0005381_digestive/alimentary_phenotyp | 0.89616800 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 0.87274157 |
| 76 | MP0002163_abnormal_gland_morphology | 0.86634510 |
| 77 | MP0005623_abnormal_meninges_morphology | 0.86221548 |
| 78 | MP0001790_abnormal_immune_system | 0.85965422 |
| 79 | MP0005387_immune_system_phenotype | 0.85965422 |
| 80 | MP0003123_paternal_imprinting | 0.85267378 |
| 81 | MP0000750_abnormal_muscle_regeneration | 0.85055928 |
| 82 | MP0005025_abnormal_response_to | 0.84451337 |
| 83 | MP0005448_abnormal_energy_balance | 0.83436329 |
| 84 | MP0001919_abnormal_reproductive_system | 0.83282694 |
| 85 | MP0003186_abnormal_redox_activity | 0.83111341 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.82204069 |
| 87 | MP0002419_abnormal_innate_immunity | 0.81604808 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.81528459 |
| 89 | MP0008872_abnormal_physiological_respon | 0.78741701 |
| 90 | MP0003045_fibrosis | 0.78174637 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.76692751 |
| 92 | MP0002067_abnormal_sensory_capabilities | 0.76469217 |
| 93 | MP0008874_decreased_physiological_sensi | 0.76427326 |
| 94 | MP0004133_heterotaxia | 0.76349368 |
| 95 | MP0001486_abnormal_startle_reflex | 0.75948348 |
| 96 | MP0001664_abnormal_digestion | 0.75742445 |
| 97 | MP0005166_decreased_susceptibility_to | 0.75517402 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.75485253 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.75449203 |
| 100 | MP0003633_abnormal_nervous_system | 0.75013971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.27774539 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.27774539 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.27774539 |
| 4 | Dysostosis multiplex (HP:0000943) | 3.25634081 |
| 5 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.16846368 |
| 6 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.16846368 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.16846368 |
| 8 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.15562831 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13528499 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.00531052 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.99632444 |
| 12 | Type II lissencephaly (HP:0007260) | 2.98218872 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 2.89686580 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.89686580 |
| 15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.85713801 |
| 16 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.85713801 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 2.82906915 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81486170 |
| 19 | Mesangial abnormality (HP:0001966) | 2.79832428 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.78849981 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78849981 |
| 22 | Mutism (HP:0002300) | 2.70754610 |
| 23 | Retinal atrophy (HP:0001105) | 2.52419157 |
| 24 | Polyphagia (HP:0002591) | 2.49010763 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 2.46972873 |
| 26 | Hyperthyroidism (HP:0000836) | 2.42978868 |
| 27 | Visual hallucinations (HP:0002367) | 2.41634223 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 2.39498901 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 2.39498901 |
| 30 | Abnormal ciliary motility (HP:0012262) | 2.37564570 |
| 31 | Myokymia (HP:0002411) | 2.36687020 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.31400104 |
| 33 | Decreased circulating renin level (HP:0003351) | 2.30920586 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 2.29016193 |
| 35 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.27274210 |
| 36 | Diplopia (HP:0000651) | 2.21089126 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.21089126 |
| 38 | Nasal polyposis (HP:0100582) | 2.20253565 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18764879 |
| 40 | Polydipsia (HP:0001959) | 2.13660079 |
| 41 | Abnormal drinking behavior (HP:0030082) | 2.13660079 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.10191074 |
| 43 | Prolonged QT interval (HP:0001657) | 2.09046416 |
| 44 | Joint stiffness (HP:0001387) | 1.98747632 |
| 45 | Follicular hyperkeratosis (HP:0007502) | 1.98373775 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 1.98193172 |
| 47 | Abnormal EKG (HP:0003115) | 1.96508009 |
| 48 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.90157317 |
| 49 | Clumsiness (HP:0002312) | 1.90141549 |
| 50 | Axonal loss (HP:0003447) | 1.89573796 |
| 51 | Peritonitis (HP:0002586) | 1.87918724 |
| 52 | Neurofibrillary tangles (HP:0002185) | 1.86103612 |
| 53 | Absent speech (HP:0001344) | 1.85420873 |
| 54 | Genu recurvatum (HP:0002816) | 1.84205570 |
| 55 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83587263 |
| 56 | Agitation (HP:0000713) | 1.83078092 |
| 57 | Ventricular fibrillation (HP:0001663) | 1.82967024 |
| 58 | Abnormality of magnesium homeostasis (HP:0004921) | 1.81757240 |
| 59 | Pancreatic cysts (HP:0001737) | 1.80730892 |
| 60 | Hyperparathyroidism (HP:0000843) | 1.80535459 |
| 61 | Cystic liver disease (HP:0006706) | 1.78758037 |
| 62 | Craniofacial dystonia (HP:0012179) | 1.78490876 |
| 63 | Petechiae (HP:0000967) | 1.78274493 |
| 64 | Myositis (HP:0100614) | 1.77949104 |
| 65 | Akinesia (HP:0002304) | 1.75531123 |
| 66 | Ileus (HP:0002595) | 1.75525471 |
| 67 | Bulbous nose (HP:0000414) | 1.75514228 |
| 68 | Focal dystonia (HP:0004373) | 1.74556546 |
| 69 | Retinal dysplasia (HP:0007973) | 1.72612866 |
| 70 | Hypoventilation (HP:0002791) | 1.71978075 |
| 71 | Purpura (HP:0000979) | 1.69296129 |
| 72 | Abnormality of macrophages (HP:0004311) | 1.68750531 |
| 73 | Nephronophthisis (HP:0000090) | 1.68694834 |
| 74 | Stomatitis (HP:0010280) | 1.67499160 |
| 75 | Thin bony cortex (HP:0002753) | 1.66736521 |
| 76 | Hydroxyprolinuria (HP:0003080) | 1.66201964 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 1.66201964 |
| 78 | Severe muscular hypotonia (HP:0006829) | 1.66168313 |
| 79 | Decreased central vision (HP:0007663) | 1.65624482 |
| 80 | Orchitis (HP:0100796) | 1.64458865 |
| 81 | Buphthalmos (HP:0000557) | 1.63746417 |
| 82 | Delusions (HP:0000746) | 1.63291816 |
| 83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.62960330 |
| 84 | Breast hypoplasia (HP:0003187) | 1.62251686 |
| 85 | Broad metatarsal (HP:0001783) | 1.61770847 |
| 86 | Protruding tongue (HP:0010808) | 1.61181488 |
| 87 | Cerebellar dysplasia (HP:0007033) | 1.60242721 |
| 88 | Torticollis (HP:0000473) | 1.59169730 |
| 89 | Nuclear cataract (HP:0100018) | 1.59145569 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 1.59103320 |
| 91 | Protrusio acetabuli (HP:0003179) | 1.59037665 |
| 92 | Abnormal hemoglobin (HP:0011902) | 1.58670592 |
| 93 | Acne (HP:0001061) | 1.58636661 |
| 94 | Intellectual disability, progressive (HP:0006887) | 1.58066855 |
| 95 | Bone cyst (HP:0012062) | 1.58042853 |
| 96 | Dementia (HP:0000726) | 1.57779523 |
| 97 | Increased corneal curvature (HP:0100692) | 1.57403454 |
| 98 | Keratoconus (HP:0000563) | 1.57403454 |
| 99 | Congenital glaucoma (HP:0001087) | 1.56823622 |
| 100 | Concave nail (HP:0001598) | 1.56540713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 2.58089985 |
| 2 | ADRBK2 | 2.57252696 |
| 3 | MAP3K11 | 2.32400039 |
| 4 | PINK1 | 2.07107660 |
| 5 | DAPK2 | 1.97082520 |
| 6 | SIK2 | 1.95312166 |
| 7 | LIMK1 | 1.78729754 |
| 8 | TRIB3 | 1.73725151 |
| 9 | MAPK15 | 1.65538344 |
| 10 | SIK1 | 1.61707962 |
| 11 | ABL2 | 1.59913367 |
| 12 | MAP3K13 | 1.55462514 |
| 13 | PRKD3 | 1.53409964 |
| 14 | IRAK3 | 1.53198101 |
| 15 | TLK1 | 1.53079971 |
| 16 | EPHB2 | 1.52032975 |
| 17 | PRKD2 | 1.50991372 |
| 18 | TESK1 | 1.50161998 |
| 19 | GRK1 | 1.49659086 |
| 20 | GRK7 | 1.37981475 |
| 21 | FRK | 1.34563340 |
| 22 | GRK5 | 1.34335673 |
| 23 | ADRBK1 | 1.33410652 |
| 24 | MAPKAPK3 | 1.26493689 |
| 25 | MYLK | 1.24772341 |
| 26 | WNK4 | 1.24175715 |
| 27 | CAMKK1 | 1.24109294 |
| 28 | MARK1 | 1.22420865 |
| 29 | TAOK1 | 1.19507285 |
| 30 | CDC42BPA | 1.18542257 |
| 31 | PTK2B | 1.16216830 |
| 32 | MARK2 | 1.13854706 |
| 33 | IRAK4 | 1.12253074 |
| 34 | STK38 | 1.11423250 |
| 35 | MARK3 | 1.10448963 |
| 36 | NME2 | 1.10038225 |
| 37 | CDK19 | 1.09110312 |
| 38 | IKBKB | 1.07643422 |
| 39 | TNK2 | 1.07171612 |
| 40 | MAP3K3 | 1.06537355 |
| 41 | DDR2 | 1.04887332 |
| 42 | IRAK2 | 1.04370535 |
| 43 | MAP2K6 | 1.01709879 |
| 44 | ACVR1B | 1.01277810 |
| 45 | CAMKK2 | 1.00770564 |
| 46 | MAP2K3 | 0.99550045 |
| 47 | GRK6 | 0.98852402 |
| 48 | TBK1 | 0.97896772 |
| 49 | PDPK1 | 0.96658231 |
| 50 | TGFBR2 | 0.96259116 |
| 51 | MAP4K1 | 0.94821572 |
| 52 | ARAF | 0.94628787 |
| 53 | PRKG2 | 0.92703069 |
| 54 | MAPK13 | 0.91816031 |
| 55 | RIPK4 | 0.91009886 |
| 56 | CAMK1 | 0.90910663 |
| 57 | TAOK2 | 0.90097080 |
| 58 | HIPK2 | 0.90018777 |
| 59 | TAOK3 | 0.87962885 |
| 60 | MAPK12 | 0.87735759 |
| 61 | RPS6KA2 | 0.87298236 |
| 62 | PAK6 | 0.87048089 |
| 63 | PIM2 | 0.79215353 |
| 64 | MAP2K2 | 0.78067276 |
| 65 | DAPK3 | 0.76525882 |
| 66 | MAP3K1 | 0.76139848 |
| 67 | RIPK1 | 0.75705499 |
| 68 | PRKCH | 0.75549045 |
| 69 | ZAP70 | 0.73670296 |
| 70 | STK11 | 0.72748871 |
| 71 | MOS | 0.72221771 |
| 72 | LMTK2 | 0.71476938 |
| 73 | PHKG1 | 0.70019518 |
| 74 | PHKG2 | 0.70019518 |
| 75 | RPS6KA6 | 0.67649106 |
| 76 | PDK1 | 0.65773727 |
| 77 | NTRK3 | 0.63902221 |
| 78 | TYRO3 | 0.63855033 |
| 79 | ILK | 0.63720746 |
| 80 | CHUK | 0.62820745 |
| 81 | PRKCG | 0.61493307 |
| 82 | BRAF | 0.57391817 |
| 83 | MAP3K9 | 0.56807933 |
| 84 | PKN1 | 0.54737779 |
| 85 | PRKCQ | 0.54149527 |
| 86 | PRKCZ | 0.54020621 |
| 87 | PAK3 | 0.53017184 |
| 88 | MATK | 0.49659560 |
| 89 | EPHB1 | 0.49275360 |
| 90 | DYRK2 | 0.48232942 |
| 91 | RPS6KC1 | 0.47576258 |
| 92 | RPS6KL1 | 0.47576258 |
| 93 | KIT | 0.46435648 |
| 94 | NTRK2 | 0.46252645 |
| 95 | SGK494 | 0.46173439 |
| 96 | SGK223 | 0.46173439 |
| 97 | PRKCD | 0.41506055 |
| 98 | CDK5 | 0.41150636 |
| 99 | MAP2K1 | 0.41135975 |
| 100 | PTK2 | 0.40547053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.84105593 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28778029 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.19502070 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 1.96600792 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 1.76996573 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72066018 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68783478 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66014857 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54513486 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34088496 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33988302 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32667011 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.31291670 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25092763 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24154485 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.22807300 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.14091975 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.12615209 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12299575 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09879353 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09878704 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07574311 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07056090 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06843183 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05847355 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05011509 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04326063 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03836439 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01673426 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01135018 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00808195 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99034716 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98929603 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 0.97733688 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96334155 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94034946 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93574108 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91678991 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87364879 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87040534 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86899247 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85435889 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85107821 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84979341 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83938284 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82714898 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81939976 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79785310 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79514116 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.76112781 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75279031 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75124402 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75082127 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75042941 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74173997 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73624560 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73315768 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72615240 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.72530582 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72420589 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72302710 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70671578 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70578644 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69485095 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69327248 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68861196 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67838780 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66593244 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66416358 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65949124 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65629121 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.64440701 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64281671 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.63655581 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62346604 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61574725 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61162241 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59745191 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58020485 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.57949275 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57496435 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56939777 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56731381 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55799201 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55311691 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55130838 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55088321 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54859742 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54738257 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54297166 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53962745 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53004211 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52766230 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52238334 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52157545 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51384867 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.51185817 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.50845765 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50106981 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49388935 |

